1. AB0211 DIFFERENTIAL INFLUENCE OF CDAI COMPONENTS BASED ON DISEASE STATE IN RHEUMATOID ARTHRITIS PATIENTS: REAL-WORLD RESULTS FROM THE ONTARIO BEST PRACTICES RESEARCH INITIATIVE (OBRI). (2nd June 2020) Authors: Keystone, E.; Movahedi, M.; Cesta, A.; Bombardier, C.; Sampalis, J.; Rampakakis, E. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 1406 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. AB0236 What Level of Disease Activity at 6 Months Predicts Achieving or Sustaining Remission at 12 Months?. (10th June 2014) Authors: Keystone, E.; Baer, P.; Haraoui, B.; Avina-Zubieta, J.A.; Chow, A.; Sholter, D.; Choquette, D.; Rampakakis, E.; Sampalis, J.S.; Nantel, F.; Lehman, A.J.; Shawi, M.; Otawa, S. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 881 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. AB0251 Early Onset of Benefit by Patient-Reported Outcomes (PROs) with Sarilumab Treatment in RA. (15th July 2016) Authors: Strand, V.; Chen, C.; Mahajan, P.; Kosinski, M.; Mangan, E.K.; van Hoogstraten, H.; Graham, N.; Lin, Y.; Keystone, E.; Braun, J. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 984 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. AB0251 The Impact of Missing Anti-Citrullinated Protein Antibody (ACPA) Serology on Outcomes in Early Rheumatoid Arthritis: Results from Catch (Canadian Early Arthritis Cohort). (10th June 2014) Authors: Shu, J.; Bykerk, V.; Boire, G.; Haraoui, B.; Hitchon, C.; Thorne, C.; Tin, D.; Keystone, E.; Pope, J. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 886 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. AB0267 Five-year safety and efficacy of golimumab in patients with active rheumatoid arthritis despite prior treatment with methotrexate: final study results of the phase 3, randomized placebo-controlled go-forward trial. (23rd January 2014) Authors: Keystone, E.; Genovese, M. C.; Hall, S.; Miranda, P. C.; Bae, S.-C.; Han, C.; Gathany, T.; Zhou, Y.; Xu, S.; Hsia, E. C. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A867 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. AB0276 Characteristics of Patients with Early Rheumatoid Arthritis (ERA) Over Time: Data from the Catch Cohort Demonstrate that More Patients Achieve Remission in Recent Years. (9th June 2015) Authors: Pope, J.E.; Haraoui, B.P.; Boire, G.; Hitchon, C.; Thorne, C.; Tin, D.; Keystone, E.; Bykerk, V.P. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 984 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. AB0284 Long term safety of iv golimumab and comparisons with sc golimumab in rheumatologic conditions: results from the 120-day safety report of go-further trial. (23rd January 2014) Authors: Westhovens, R.; Bingham, C. O.; Weinblatt, M.; Fleischmann, R.; Keystone, E.; Hsia, E. C.; Hsu, B.; Kim, L.; Mudivarthy, S.; Mack, M.; Goldstein, N.; Braun, J.; Kavanaugh, A.; Mendelsohn, A.; Kay, J. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A873 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. AB0304 What Proportion of Patients Fail to Achieve Das, Cdai, Sdai Remission Based on Patient Global assessment? An Analysis from a Prospective, Observational Registry. (9th June 2015) Authors: Baer, P.; Keystone, E.; Bensen, W.; Thorne, C.; Haraoui, B.; Choquette, D.; Arendse, R.; Kelsall, J.; Sheriff, M.; Sampalis, J.; Rampakakis, E.; Tkaczyk, C.; Shawi, M.; Lehman, A.; Nantel, F.; Otawa, S. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 995 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. AB0315 Reduction of Concomitant Oral Methotrexate or Corticosteroids in Combination Treatment with Adalimumab Does Not Affect Effectiveness in Patients with Rheumatoid Arthritis. (15th July 2016) Authors: Keystone, E.; Breedveld, F.; Kavanaugh, A.; Zhang, Y.; Sainsbury, I.; Kalabic, J. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 1008 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. AB0377 Clinical, Functional, and Structural Consequences of Targeting Low Disease Activity Rather than Remission in Early and Established Rheumatoid Arthritis Using Methotrexate or Methotrexate plus Adalimumab. (10th June 2014) Authors: Aletaha, D.; Keystone, E.; Kupper, H.; Liu, S.; Florentinus, S.; van Vollenhoven, R.F. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 930 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗